Controlled temperature to the max

sense the heat and make sure it is where it should be

feel the heat

center your focus on the patient and put the patient in control

sensible treatment is only possible with planning and control

plans are useless, planning is essential in order to adapt to reality

Sense in thermal therapy

500 000 new patients get diagnosed with head and neck cancer each year - half of them are confronted with recurring tumors: patients need better treatment options

News

In May 2018 Sensius established an Advisory Board with board members with specific knowledge and experience on financing of startups, marketing and sales and a large global network within the field of oncology. Therefore, we are very happy to announce that Michel Rudolphie and Reender Beks, people with a strong connection to the working fields of Sensius, have accepted being a member or our Board of Advice.

read more...

Watch the short introduction to thermotherapy for head and neck cancer and Sensius

new and proven technology

new and proven technology
Thermal therapy with deep treatment of head&neck now becomes possible. The solution is actively applied in medical practice and is in preparation for wide availability

team

team
In Sensius, the medical team collaborates with business in order to build a solution that meets the clinical needs

scientific background

scientific background
Many publications are already available. Click here for further reading

For Patients

For Patients
There is now a strong evidence base for applying thermal therapy to treat tumors in the head and neck region.

Endorsement

Endorsement
Our ambition is supported by Erasmus MC and many other researchers and physicians

News

News
Read the most recent news

Sense in thermotherapy

500 000 New patients worldwide get diagnosed with head and neck cancer annually. Treatment is very challenging. International biological research has proven that thermal therapy attacks cancer cells. The HyperCollar3D, developed by Erasmus MC, steers the heat to the tumor while avoiding sensitive organs. This therapy should be available worldwide - Sensius will deliver.